Literature DB >> 23576484

Geographic tongue induced by angiogenesis inhibitors.

Thomas Hubiche, Bruno Valenza, Christine Chevreau, Jean-Christophe Fricain, Pascal Del Giudice, Vincent Sibaud.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23576484      PMCID： PMC3639539          DOI： 10.1634/theoncologist.2012-0320

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  6 in total

Review 1.  Benign migratory glossitis or geographic tongue: an enigmatic oral lesion.

Authors:  Dimitrios Assimakopoulos; George Patrikakos; Christina Fotika; Moses Elisaf
Journal:  Am J Med       Date:  2002-12-15       Impact factor: 4.965

2.  Characteristics of oral mucosal events related to bevacizumab treatment.

Authors:  Igor T Gavrilovic; Yevgeniy Balagula; Alyx C Rosen; Vijay Ramaswamy; Maura N Dickler; Ira J Dunkel; Mario E Lacouture
Journal:  Oncologist       Date:  2012-01-26

3.  Vascular endothelial growth factor localization in the adult.

Authors:  Arindel S R Maharaj; Magali Saint-Geniez; Angel E Maldonado; Patricia A D'Amore
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 4.  Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review.

Authors:  Christine B Boers-Doets; Joel B Epstein; Judith E Raber-Durlacher; Jan Ouwerkerk; Richard M Logan; Jan A Brakenhoff; Mario E Lacouture; Hans Gelderblom
Journal:  Oncologist       Date:  2011-12-29

5.  Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.

Authors:  W J Lee; J L Lee; S E Chang; M W Lee; Y K Kang; J H Choi; K C Moon; J K Koh
Journal:  Br J Dermatol       Date:  2009-05-05       Impact factor: 9.302

6.  Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.

Authors:  Guolin Zhou; Rifat Hasina; Kristen Wroblewski; Tanmayi P Mankame; Colleen L Doçi; Mark W Lingen
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26
  6 in total
  7 in total

1.  Geographical tongue induced by axitinib.

Authors:  Santhanam Sundar; Frances Burge
Journal:  BMJ Case Rep       Date:  2015-10-16

2.  Non-invasive intravital observation of lingual surface features using sliding oral mucoscopy techniques in clinically healthy subjects.

Authors:  Satoko Tsuchida; Ken Yoshimura; Naoki Nakamura; Naoki Asanuma; Shin-Ichi Iwasaki; Yukio Miyagawa; Shinichi Yamagiwa; Takashi Ebihara; Yuko Morozumi; Tomoichiro Asami; Naoki Kosuge
Journal:  Odontology       Date:  2019-07-15       Impact factor: 2.634

3.  In reply.

Authors:  Alyx C Rosen; Igor T Gavrilovic; Yevgeniy Balagula; Vijay Ramaswamy; Maura N Dickler; Ira J Dunkel; Mario E Lacouture
Journal:  Oncologist       Date:  2013-04-10

Review 4.  Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.

Authors:  Emmanuelle Vigarios; Joel B Epstein; Vincent Sibaud
Journal:  Support Care Cancer       Date:  2017-02-22       Impact factor: 3.603

Review 5.  Paediatric Geographic Tongue: A Case Report, Review and Recent Updates.

Authors:  Doddabasavaiah Basavapur Nandini; Shivanand Bagalad Bhavana; Byathnal Suryakanth Deepak; Ramakrishna Ashwini
Journal:  J Clin Diagn Res       Date:  2016-02-01

Review 6.  Oral adverse effects: drug-induced tongue disorders.

Authors:  Yalda Aziz; Willem Maria Hubertus Rademacher; Atty Hielema; Scott Bradley Patton Wishaw; Denise Edwina van Diermen; Jan de Lange; Arjan Vissink; Frederik Reinder Rozema
Journal:  Oral Dis       Date:  2020-11-03       Impact factor: 3.511

Review 7.  Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails.

Authors:  Mario Lacouture; Vincent Sibaud
Journal:  Am J Clin Dermatol       Date:  2018-11       Impact factor: 7.403
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.